(0.56%) 5 156.26 points
(0.29%) 38 786 points
(0.61%) 16 255 points
(0.96%) $78.86
(3.03%) $2.21
(1.07%) $2 333.30
(3.33%) $27.58
(0.39%) $969.05
(-0.18%) $0.927
(-0.58%) $10.81
(-0.29%) $0.795
(-0.05%) $91.41
Live Chart Being Loaded With Signals
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation...
Stats | |
---|---|
आज की मात्रा | 460 710 |
औसत मात्रा | 437 269 |
बाजार मूल्य | 19.42M |
EPS | $0 ( 2024-04-04 ) |
अगली कमाई की तारीख | ( $0 ) 2024-05-13 |
Last Dividend | $0.240 ( 2023-01-13 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0247 |
ATR14 | $0.0370 (7.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Luo Ying | Buy | 3 350 897 | Stock Option (Right to Buy) |
2023-10-30 | Luo Ying | Buy | 2 840 376 | Common Stock |
2023-11-20 | Luo Ying | Buy | 2 262 755 | Stock Option (Right to Buy) |
2023-11-20 | Ye Weiguo | Buy | 1 665 115 | Stock Option (Right to Buy) |
2023-11-20 | Ma Songjiang | Buy | 4 510 047 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
24.88 |
Last 85 transactions |
Buy: 88 748 347 | Sell: 111 334 812 |
मात्रा सहसंबंध
Catalyst Biosciences Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
CALA | 0.925 |
ODT | 0.917 |
UPC | 0.909 |
BCAB | 0.908 |
NBIX | 0.897 |
LLNW | 0.891 |
ENNV | 0.891 |
LFMD | 0.891 |
YJ | 0.889 |
XPDI | 0.889 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
SHC | -0.922 |
WYNN | -0.921 |
DSPG | -0.917 |
ACLS | -0.913 |
PPD | -0.908 |
BNIX | -0.907 |
DUNE | -0.906 |
RVNC | -0.902 |
HHGC | -0.901 |
FWONK | -0.899 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Catalyst Biosciences Inc सहसंबंध - मुद्रा/वस्त्र
Catalyst Biosciences Inc वित्तीय
Annual | 2022 |
राजस्व: | $794 000 |
सकल लाभ: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2022 |
राजस्व: | $794 000 |
सकल लाभ: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2021 |
राजस्व: | $0.00 |
सकल लाभ: | $-7.38M (0.00 %) |
EPS: | $-2.87 |
FY | 2020 |
राजस्व: | $20.95M |
सकल लाभ: | $11.79M (56.26 %) |
EPS: | $-2.93 |
Financial Reports:
No articles found.
Catalyst Biosciences Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$1.430 (N/A) |
$0 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $59.77 | 2015-08-20 |
Last Dividend | $0.240 | 2023-01-13 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $61.44 | -- |
Avg. Dividend % Per Year | 39.53% | -- |
Score | 4.37 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.002 | |
Div. Directional Score | 0.464 | -- |
Year | Amount | Yield |
---|---|---|
2015 | $59.77 | 22.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $1.430 | 143.00% |
2023 | $0.240 | 41.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 55.72 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.709 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 12.04 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | -0.289 | -1.000 | -2.89 | 2.89 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -71.39 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.176 | -0.352 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 3.15 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 55.75 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | -0.0127 | 0.800 | -3.42 | -2.73 | [0.5 - 2] |
Total Score | -0.0749 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.439 | 1.000 | -0.145 | 0 | [1 - 100] |
returnOnEquityTTM | 12.04 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.352 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
payoutRatioTTM | -0.289 | 1.500 | -2.89 | 2.89 | [0 - 1] |
pegRatioTTM | -0.00352 | 1.500 | -3.36 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 16.85 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 1.002 |
Catalyst Biosciences Inc
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं